Revance Therapeutics, Inc.
SEC Filing List
RVNC CIK: 0001479290
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | GLAZER CAPITAL, LLC /fa | 05/15/2025 | |||
| SCHEDULE 13G/A | SHARTSIS FRIESE LLP /fa | 05/15/2025 | |||
| SCHEDULE 13G/A | JPMORGAN CHASE & CO /fa | 03/06/2025 | |||
| 15-12G | Notice of termination of registration of... | Revance Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/18/2025 | |
| SCHEDULE 13G/A | Palo Alto Investors LP /fa | 02/13/2025 | |||
| S-8 POS | Post-effective amendment to a S-8 regist... | Revance Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2025 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Revance Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2025 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Revance Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2025 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Revance Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2025 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Revance Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2025 | |
| No record found. | |||||
| Load More | |||||
